Phreesia [PHR] vs Omnicell [OMCL] Detailed Stock Comparison

Phreesia Inc.

NYSE
Loading...

Omnicell Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Phreesia Inc. wins in 9 metrics, Omnicell Inc. wins in 10 metrics, with 1 ties. Omnicell Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Phreesia Inc. Omnicell Inc. Better
P/E Ratio (TTM) 229.25 918.75 Phreesia Inc.
Price-to-Book Ratio 1.65 1.34 Omnicell Inc.
Debt-to-Equity Ratio 30.38 16.59 Omnicell Inc.
PEG Ratio -1.94 -8.01 Phreesia Inc.
EV/EBITDA 28.43 36.82 Phreesia Inc.
Profit Margin (TTM) 0.48% 0.17% Phreesia Inc.
Operating Margin (TTM) 1.33% 2.20% Omnicell Inc.
EBITDA Margin (TTM) 1.33% 2.20% Omnicell Inc.
Return on Equity 0.77% 0.17% Phreesia Inc.
Return on Assets (TTM) 0.31% 0.36% Omnicell Inc.
Free Cash Flow (TTM) $54.42M $69.37M Omnicell Inc.
1-Year Return -59.74% 45.34% Omnicell Inc.
Price-to-Sales Ratio (TTM) 1.16 1.41 Phreesia Inc.
Enterprise Value $587.51M $1.68B Omnicell Inc.
EV/Revenue Ratio 1.22 1.42 Phreesia Inc.
Gross Profit Margin (TTM) 68.21% 41.51% Phreesia Inc.
Revenue per Share (TTM) $8 $26 Omnicell Inc.
Earnings per Share (Diluted) $0.04 $0.04 Tie
Beta (Stock Volatility) 0.86 0.86 Phreesia Inc.
Short % of Float 6.70% 6.68% Omnicell Inc.

Phreesia Inc. vs Omnicell Inc. Stock Performance Analysis

Loading Price Chart...

PHR
OMCL

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Phreesia Inc.-6.85%5.70%-0.21%-21.99%-52.65%-40.80%
Omnicell Inc.-0.05%-2.85%-3.57%2.67%3.48%-7.20%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Phreesia Inc.-59.74%-69.80%-81.61%-58.92%-58.92%-58.92%
Omnicell Inc.45.34%-40.34%-68.37%35.61%212.38%209.75%

Performance & Financial Health Analysis: Phreesia Inc. vs Omnicell Inc.

MetricPHROMCL
Market Information
Market Cap i$568.74M$1.65B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i2,132,160390,030
90 Day Avg. Volume i2,487,373505,763
Last Close$9.65$41.89
52 Week Range$7.77 - $32.76$26.85 - $55.00
% from 52W High-70.54%-23.84%
All-Time High$81.59 (Feb 08, 2021)$187.29 (Nov 22, 2021)
% from All-Time High-88.17%-77.63%
Growth Metrics
Quarterly Revenue Growth0.16%0.02%
Quarterly Earnings Growth0.16%N/A
Financial Health
Profit Margin (TTM) i0.00%0.00%
Operating Margin (TTM) i0.01%0.02%
Return on Equity (TTM) i0.01%0.00%
Debt to Equity (MRQ) i30.3816.59
Cash & Liquidity
Book Value per Share (MRQ)$5.56$27.36
Cash per Share (MRQ)$1.19$4.33
Operating Cash Flow (TTM) i$78.81M$127.30M
Levered Free Cash Flow (TTM) i$55.70M$94.53M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00N/A

Valuation & Enterprise Metrics Analysis: Phreesia Inc. vs Omnicell Inc.

MetricPHR (Apr 21, 2026)OMCL (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i229.25918.75
Forward P/E i5.4217.60
PEG Ratio i-1.94-8.01
Price to Sales (TTM) i1.161.41
Price to Book (MRQ) i1.651.34
Market Capitalization
Market Capitalization i$568.74M$1.65B
Enterprise Value i$587.51M$1.68B
Enterprise Value Metrics
Enterprise to Revenue i1.221.42
Enterprise to EBITDA i28.4336.82
Risk & Other Metrics
Beta i0.860.86
Book Value per Share (MRQ) i$5.56$27.36

Financial Statements Comparison: Phreesia Inc. vs Omnicell Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricPHR (2026)OMCL (2025)
Revenue/Sales i480.59M1.18B
Cost of Goods Sold i154.12M681.40M
COGS % of Revenue i32.1%57.5%
Gross Profit i326.47M503.44M
Gross Margin i67.9%42.5%
Research & Development i121.48M88.67M
Operating Income (EBIT) i-6.61M5.16M
Operating Margin i-1.4%0.4%
EBITDA i29.97M91.79M
EBITDA Margin i6.2%7.7%
Pre-Tax Income i-8.94M11.33M
Pre-Tax Income % of Revenue i-1.9%1.0%
Income Tax i-11.25M9.27M
Income Tax % of Revenue i-2.3%0.8%
Net Income (Profit) i2.31M2.05M
Profit Margin i0.5%0.2%

Balance Sheet & Liquidity Metrics

MetricPHR (2026)OMCL (2025)
Cash & Equivalents i73.83M196.52M
Total Current Assets i279.84M680.07M
Total Current Assets % of Revenue i58.2%57.4%
Total Current Liabilities i183.24M476.61M
Total Current Liabilities % of Revenue i38.1%40.2%
Long-Term Debt i93.22M192.39M
Long-Term Debt % of Revenue i19.4%16.2%
Total Shareholders Equity i337.21M1.23B
Retained Earnings i-799.19M384.94M
Retained Earnings % of Revenue i-166.3%32.5%
Property, Plant & Equipment i18.53M128.44M

Cash Flow Statement Comparison

MetricPHR (2026)OMCL (2025)
Operating Cash Flow i95.42M155.13M
Operating Cash Flow % of Revenue i19.9%13.1%
Capital Expenditures i-11.10M-40.42M
Free Cash Flow i54.42M69.37M
FCF Margin i11.3%5.9%
Debt Repayment i-26.83M-175.00M
Common Stock Repurchase i0-77.60M

Short Interest & Institutional Ownership Analysis

MetricPHROMCL
Shares Short i3.91M2.50M
Short Ratio i1.674.16
Short % of Float i6.70%6.68%
Shares Outstanding i60.67M45.03M
Float Shares i48.26M41.91M
% Held by Insiders i4.72%2.20%
% Held by Institutions i114.71%106.39%
% Held by Public i-19.43%-8.59%

Dividend Analysis & Yield Comparison: Phreesia Inc. vs Omnicell Inc.

MetricPHROMCL
Last 12-Month Dividend i$0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$0.00N/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i$0.00N/A
Ex-Dividend DateN/AN/A